# Tayca Corporation – FDA Inspection, Aug 25, 2023

Source: https://www.keypedia.com/records/fda_inspections/tayca-corporation/6cd9ce85-bb7f-4a1a-9855-15ddab3b11ee
Source feed: FDA_Inspections

> FDA inspection 1219130 of Tayca Corporation, August 25, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219130
- Company Name: Tayca Corporation
- Inspection Date: 2023-08-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1038594 - 2017-12-15](https://www.keypedia.com/records/fda_inspections/tayca-corporation/4946f71a-6848-47ff-8d8d-64ca1532a937)
- FDA Inspection 989845 - 2016-09-09
- FDA Inspection 855688 - 2013-11-08
- FDA Inspection 615187 - 2009-08-27

## Related Officers

- [Company Rep](https://www.keypedia.com/people/gavin-t-cua/6f498dd6-2c4b-42e9-8ddc-3c2a7c97afef)

Company: https://www.keypedia.com/companies/tayca-corporation/46216ddd-c2d8-492b-bbc2-7011e93a98bf

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c